What is Climb Bio, Inc. Common Stock's Market Cap?

Climb Bio, Inc. Common Stock's Market Cap is $585.3M, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's Enterprise Value?

Climb Bio, Inc. Common Stock's Enterprise Value is $402.2M, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's EV / EBITDA?

Climb Bio, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's Net Income (TTM)?

Climb Bio, Inc. Common Stock's Net Income (TTM) is -$57.6M, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's EBITDA?

Climb Bio, Inc. Common Stock's EBITDA is -$64.6M, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's Diluted EPS (TTM)?

Climb Bio, Inc. Common Stock's Diluted EPS (TTM) is -1.00, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's Net Debt?

Climb Bio, Inc. Common Stock's Net Debt is -$183.1M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Climb Bio, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZNKL0L5

10.19▼ 0.35 (-3.32%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 10.54
Day's Range: 10.05 – 10.66
52-Week Range: 1.64 – 18.33
Volume: 495.5K
Avg Volume: 1.2M

Share Statistics

Shares Outstanding
Employees: 29
Exchange: XNAS
Listed: 2021-08-10

Share count as of July 31, 2026

Climb Bio, Inc. Common Stock (CLYM) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Climb Bio, Inc. Common Stock (CLYM)

What is Climb Bio, Inc. Common Stock's Market Cap?: Climb Bio, Inc. Common Stock's Market Cap is $585.3M, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's Enterprise Value?: Climb Bio, Inc. Common Stock's Enterprise Value is $402.2M, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's EV / EBITDA?: Climb Bio, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's Net Income (TTM)?: Climb Bio, Inc. Common Stock's Net Income (TTM) is -$57.6M, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's EBITDA?: Climb Bio, Inc. Common Stock's EBITDA is -$64.6M, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's Diluted EPS (TTM)?: Climb Bio, Inc. Common Stock's Diluted EPS (TTM) is -1.00, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's Net Debt?: Climb Bio, Inc. Common Stock's Net Debt is -$183.1M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · CLYMAs-filed SEC (XBRL) data